Indianapolis, IN, United States of America

William B Blanchard


Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1976-1996

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of William B. Blanchard

Introduction

William B. Blanchard is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases of the central nervous system. With a total of nine patents to his name, Blanchard's work exemplifies innovation and dedication to improving healthcare.

Latest Patents

Among his latest patents are the "Substituted pyrazolidin-3-one derivatives" and "Pyrazolidin-3-one derivatives." Both inventions provide an enantiomerically selective process and intermediates for preparing certain 4,5-disubstituted pyrazolidinones. These compounds are particularly useful for treating diseases of the central nervous system, showcasing Blanchard's commitment to advancing medical science.

Career Highlights

Blanchard is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in innovative therapies. His work at Eli Lilly has allowed him to contribute to groundbreaking research that has the potential to change lives.

Collaborations

Throughout his career, Blanchard has collaborated with esteemed colleagues such as Charles W. Ryan and Thomas Charles Britton. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of new pharmaceutical solutions.

Conclusion

William B. Blanchard's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of central nervous system diseases, making him a valuable asset to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…